German panel to recommend J&J COVID vaccine for those over 60 – Spiegel
ARKI dds comment, background
BERLIN, May 7 (Reuters) – Germany’s Vaccine Committee, known as STIKO, plans to recommend Johnson & Johnson’s JNJ.N COVID-19 vaccine only for people over 60, German magazine Der Spiegel reported on Friday, not citing any source.
The European Medicines Regulator approved J & J’s vaccine last month after reviewing cases of a rare blood clotting problem in American adults who were given a dose. But it left it up to the member states of the European Union to decide how to use it.
A spokeswoman for the Robert Koch Institute for Infectious Diseases (RKI) said the institute expects STIKO to make a recommendation on J&J’s vaccine next week. She declined to comment further.
Germany limited the shot of Anglo-Swedish pharmacist AstraZeneca AZN.L in people over 60 years after post-vaccination surveillance, rare – and sometimes fatal – cases of blood clotting have been found, with younger women disproportionately affected.
Health Minister Jens Spahn announced on Thursday that Germany will make AstraZeneca available to all adults, regardless of age, to speed up its vaccination campaign.
The federal government’s move follows steps taken by several German states to make AstraZeneca more widely available and comes as the pace of essential vaccine injections from BioNTech / Pfizer and Moderna accelerates.
(Report by Maria Sheahan edited by Riham Alkousaa and Thomas Escritt)
(([email protected]; +49 30 22013 3680;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.